COVID-19: Russian vaccine trial successful in human

Russia hands over aid memoir of COVID-19 vaccine to FG

Russia hands over aid memoir of COVID-19 vaccine to FG

Avimex, normally dedicated to the manufacture of vaccines and pharmaceutical products for animals, did not respond to a request for comment.

The vaccine was now in the phase 1 trials, being conducted at several locations around the country.

The SEC, while recommending approval, laid down the conditions that the trial sites should be different from the sites where the present clinical trials are going on for the vaccine through the intramuscular route and that the subject should be followed up for six months for clinical and antibody assessments.

The Federal Government has received an aid memoir of the Russian-made COVID-19 vaccine.

The vaccine was approved for use by Russian Federation last month, but remained a subject of much scepticism given the short timeframe in which it has been developed. "Most importantly, 100 per cent of the volunteers who were given the vaccine shots showed immune response", said GRIEM director Alexander Gintsburg. Shebarshin informed the minister that developed countries with sophisticated health care system, notably, United Arab Emirate (UAE), Saudi Arabia, Mexico and several others have indicated interest in the vaccine. "Now.we will start asking questions of some of the Western vaccines".

US Open 2020: Dominic Thiem Topples Marin Cilic
Austria's Dominic Thiem advanced to the fourth round of the ongoing US Open after defeating Croatian Marin Cilic on Sunday. The 20-year-old Auger-Aliassime also became the first player born in the 2000s to advance to a grand slam fourth round.

Under the deal with UQ and CSL, Australia will buy 51 million doses of that tie-up's vaccine. Australia has recorded more than 26,000 infections and 753 deaths.

If the results are positive, Sanofi and GSK hope to get the vaccine approved in the first half of next year. Should both vaccines prove successful, Australia has secured to right to donate or sell on without a mark-up.

Russia, which on August 11 announced that it has developed the world's first coronavirus vaccine, has faced criticism from scientists and experts for not conducting Phase 3 trials to determine its safety.

The Phase 1 trials for Covaxin began on July 15 at 12 centres across the country. A second stage will see "hundreds of patients" before thousands of volunteers take part in final Phase 3 studies.

The government would run a strong campaign to encourage people to be vaccinated, but this would not be compulsory.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.